title: Role of the low zinc bioavailability on cellular immune effectiveness in cystic fibrosis.
abstract: An altered cellular immune response as a secondary phenomenon has been suggested to be probably involved in the bronchopulmonary infections by Pseudomonas aeruginosa in cystic fibrosis (CF). The difficulty to eradicate with modern anti-pseudomonal antibiotics the bronchopulmonary infections has led us to further investigate the possible existence of other cellular immune defects and their cause. Alterations in zinc turnover are present in CF. Zinc is relevant for good immune functioning. In particular, zinc is required to confer biological activity to thymulin (ZnFTS), a biochemically defined thymic hormone with a modulating action on cell-mediated immunity. The zinc-unbound form (FTS) is inactive and it can be unmasked by in vitro zinc addition to the plasma samples revealing the total amount of circulating thymulin (active + inactive). Marginal zinc deficiencies may prevent peripheral biological activation of active thymulin. Total zinc-saturable thymulin fractions in CF are similar to those observed in normal subjects, whereas the active quota is strongly reduced associated with concomitant high plasma levels of inactive thymulin compared to the values of healthy children (P < 0.01). A strict correlation exists between zinc and thymic hormone-saturable fraction (r = 0.87, P < 0.01) in CF. These findings suggest that the defect is not due to a thymic failure but to a reduced peripheral saturation of thymulin by zinc ions. This defect might depend on augmented plasma concentration of alpha 2-macroglobulin, which has a higher binding affinity for zinc than thymulin. T cell subsets are normal in CF. Reduced NK cell number and activity are present. Also, plasma IL-2 levels are reduced. The existence of positive correlations between zinc and IL-2 (r = 0.79, P < 0.01) and between zinc or active thymulin and NK activity (r = 0.70, P < 0.01 and r = 0.88, P < 0.01, respectively) suggest a close link among zinc failure, impaired IL-2 activity, low thymulin level, and reduced NK activity in CF patients with both normal and growth retardation. Although the role of NK cells is unknown in CF, a zinc supplementation, in order to induce a complete saturation of thymulin molecules, to correct some cellular immune defects and to improve the growth, may be suggested.
authors.affiliation: Gerontology Research Department, Italian National Research Centers on Aging (I.N.R.C.A.), Ancona.
authors.forename: E
authors.initials: E
authors.lastname: Mocchegiani
authors.forename: M
authors.initials: M
authors.lastname: Provinciali
authors.forename: G
authors.initials: G
authors.lastname: Di Stefano
authors.forename: A
authors.initials: A
authors.lastname: Nobilini
authors.forename: G
authors.initials: G
authors.lastname: Caramia
authors.forename: L
authors.initials: L
authors.lastname: Santarelli
authors.forename: A
authors.initials: A
authors.lastname: Tibaldi
authors.forename: N
authors.initials: N
authors.lastname: Fabris
mesh_terms: D000293:Adolescent; D001682:Biological Availability; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007376:Interleukin-2 / Q000097:blood; D007694:Killer Cells, Natural / Q000276:immunology; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D013935:Thymic Factor, Circulating / Q000378:metabolism; D015032:Zinc / Q000097:blood*; D000511:alpha-Macroglobulins / Q000378:metabolism
chemical_list: D007376:Interleukin-2; D000511:alpha-Macroglobulins; D013935:Thymic Factor, Circulating; D015032:Zinc